Ieva M. Augstums Ieva (YEH-vuh), Deputy Vice President of Public Affairs, joined PhRMA in 2014 and now oversees all branding and paid advertising, including PhRMA’s national multi-year GOBOLDLY campaign. She reported on the 2008 financial crisis and other financial market news during ten years as a journalist at the Dallas Morning News and the Associated Press, then directed national campaigns at a Washington-based strategic communications and brand consulting firm. A native Nebraskan, Ieva is a proud mother of two, dreams of opening a paperie and never passes up an opportunity to lace up for a rave run.
Recent Posts
The Partnership for Prescription Assistance: A history of caring
By Ieva M. Augstums | November 4, 2015
America is a country of problem solvers, innovators and dreamers. In April 2005, professionals on the front lines of health care at America’s biopharmaceutical research companies, created the...
Read More
Personalized Medicine: The next health frontier
By Ieva M. Augstums | October 23, 2015
One of PhRMA’s most important roles is serving as a convener. And earlier this week we joined with The Hill to convene two terrific discussions around personalized – or precision – medicine. We do...
Read More
Sharing a Story of Hope
By Ieva M. Augstums | October 21, 2015
All of us – patients, survivors and loved ones – face challenges from the moment of a disease diagnosis through treatment. And those challenges are personal. Ten years ago, there was no such thing...
Read More
PhRMA Honors Research & Hope Award Recipients
By Ieva M. Augstums | September 11, 2015
Imagine a world without cancer. Earlier this week, a group of trailblazers in the oncology community gathered to reflect on efforts to help make this dream a reality. PhRMA was pleased to host the
Read More
From Hope to Cures: The Value of Biopharmaceutical Innovation
By Ieva M. Augstums | August 20, 2015
Biopharmaceutical innovation means more than helping patients lead longer, healthier, more productive lives. Through the continued development of new treatments and cures, each discovery...
Read More













